Clifford Starke
Known title: CEOCIK: 0001955468
Clifford Starke's purchase track record
How the stock did after each of Clifford Starke's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since April 8, 2024
Stock higher 6 months later
0%
3 months: 67%
Median 6-month return
-26.7%
3 months: +34.3%
Beat the S&P 500
0%
median -33.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/13/2024 | ZSTK | $6K | +34.3% | -35.9% | +0.2% |
| 9/5/2024 | ZSTK | $48 | +71.7% | -26.7% | +4.3% |
| 4/8/2024 | ZSTK | $1000K | -59.2% | -23.8% | +9.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ZSTK | ▲ Buy | Grant | 900,000 | — | 12/15/2024 | View on chart |
| ZSTK | ▲ Buy | Open Market | 6,795 | $6K | 9/13/2024 | View on chart |
| ZSTK | ▲ Buy | Open Market | 51 | $48 | 9/5/2024 | View on chart |
| ZSTK | ▲ Buy | Open Market | 526,315 | $1000K | 4/8/2024 | View on chart |
| ZSTK | ▲ Buy | Grant | 327,851 | — | 11/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ZeroStack Corp. noted among health‑care stocks moving in pre‑market
ZeroStack Corp. appeared in a Benzinga list of health‑care stocks that showed price movement in Friday’s pre‑market session. The mention highlights short‑term interest in the stock ahead of regular trading. The stock is currently near its $1.70 support level, with an RSI around the mid‑40s.
ZeroStack Corp. noted among health‑care stocks moving in pre‑market. ZeroStack Corp. appeared in a Benzinga list of health‑care stocks that showed price movement in Friday’s pre‑market session. The mention highlights short‑term interest in the stock ahead of regular trading. The stock is currently near its $1.70 support level, with an RSI around the mid‑40s.